Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
US9718873B2 · kind B2 · utility
0Cited by
2References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 3, 2014 |
| Grant date | Aug 1, 2017 |
| Priority date | — |
| Expiry date | Feb 3, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features a novel influenza antibody that specifically binds to influenza hemagglutinin and reduces or inhibits hemagglutinin binding to sialic acid. The invention also provides methods, compositions, and kits featuring the novel antibody and its use in preventing or treating influenza infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.